Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease
Nutrients · 2024
DOI: 10.3390/nu16111668 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Jelena Popov und 7 weiteren Autor:innen. Beteiligte Einrichtung: Boston Combined Residency Program, Boston Children's Hospital & Boston Medical Center, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Disease Progression. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent type of liver disease worldwide. The exact pathophysiology behind MASLD remains unclear; however, it is thought that a combination of factors or “hits” act as precipitants for disease onset and progression. Abundant evidence supports the roles of diet, genes, metabolic dysregulation, and the intestinal microbiome in influencing the accumulation of lipids in hepatocytes and subsequent progression to inflammation and fibrosis. Currently, there is no cure for MASLD, but lifestyle changes have been the prevailing cornerstones of management. Research is now focusing on the intestinal microbiome as a potential therapeutic target for MASLD, with the spotlight shifting to probiotics, antibiotics, and fecal microbiota transplantation. In this review, we provide an overview of how intestinal microbiota interact with the immune system to contribute to the pathogenesis of MASLD and metabolic dysfunction-associated steatohepatitis (MASH). We also summarize key microbial taxa implicated in the disease and discuss evidence supporting microbial-targeted therapies in its management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Boston Combined Residency Program, Boston Children's Hospital & Boston Medical Center, Boston, MA 02115, USA.
- College of Medicine and Health, University College Cork, T12 YN60 Cork, Ireland.
- Department of Pediatric Gastroenterology, Hepatology & Nutrition, The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1E8, Canada.
- School of Medicine, University College Dublin, D04 C1P1 Dublin, Ireland.
- Department of Pediatrics, Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.
- Department of Medical Sciences, Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.
ORCID-Profile: Jelena Popov, David Avelar Rodriguez, Eugene Mech, Mahrukh Khan, Nikhil Pai
Zitieren
APA
Popov, J., Despot, T., Avelar Rodriguez, D., Khan, I., Mech, E., Khan, M., Bojadzija, M., & Pai, N. (2024). Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. Nutrients. https://doi.org/10.3390/nu16111668
Vancouver
Popov J, Despot T, Avelar Rodriguez D, Khan I, Mech E, Khan M, et al. Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. Nutrients. 2024. doi:10.3390/nu16111668
BibTeX
@article{Popov2024,
author = {Popov, Jelena and Despot, Tijana and Avelar Rodriguez, David and Khan, Irfan and Mech, Eugene and Khan, Mahrukh and Bojadzija, Milan and Pai, Nikhil},
title = {Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16111668}
}
EUVIMED